| HOME >> MEDICINE >> TECHNOLOGY |
NEW YORK, Dec. 2 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Chiral Technology - International Technology & Market Trends
The fast developing small molecule chiral technology sector is witnessing a flurry of activity with pharmaceutical companies adding chiral expertise to their portfolios. Several leading pharmaceuticals such as Lipitor, Zocor, Advair, Norvasc and Viagra are chiral based. While conventional processes of chiral production such as resolution and chiral pool chemistry are time-tested methods, emerging asymmetric and biological methods are also the focus of attention, garnering significant research dollars. Over the past few years, technological progress has had a growing influence on pharmaceutical research and development - almost 90% of all drugs in the pipeline are chiral based.
These and other market data and trends are presented in "Chiral Technology: International Technology & Market Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
CHIRAL TECHNOLOGY BMR-1012
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3
2. GLOBAL MARKET OVERVIEW 4
An Insight into Chiral Technology 4
Techniques Used for Achieving Single-Isomers 5
Importance and Advancements 6
Market Trends 6
Good Tidings for Chiral Technology 6
Outlook 8
Market Drivers 8
Demand for Chiral-based Therapeutic Drugs Augments Growth 8
New Legislations Push Chiral Technology Demand 8
Key Trends 8
Organizations Extend Approaches 8
Companies' Association with Universities 9
3. PRODUCT FACTS 9
Chiral Technology 9
Chiral Technology Enabling Products 9
Chiral Intermediates 9
Analytical Products 10
Other Products 10
Chiral Technology End-Use Markets 10
Pharmaceuticals 10
Agrochemicals 10
Chiral Isomerism 10
Organic Chemical Isomerism Types 10
Select Companies Involved in Chiral Technology Market 11
4. CHIRAL TECHNOLOGY - DEVELOPMENT VS. ACQUISITION 12
In-House Creation & Development 12
Acquisition of Technology 12
"Economics" of Chiral Technology 13
5. REGULATORY & ENVIRONMENTAL ISSUES 14
6. CORPORATE DEVELOPMENTS 15
Cambrex to Buy ProSyntest AS 15
Johnson Matthey and X-Zyme Sign Licensing Agreement 15
Chiral Quest Starts a New Production Facility 15
Chiral Quest Completes Reverse Merger with Surg II 15
DSM and IEP Extend Partnership 16
Degussa Develops Novel Processes to Synthesize (S) CAP 16
Regis Technologies, Inc. Launches RegisPack Chiral Columns 16
Sigma-Aldrich Introduces ChiroSolv(TM) Kits 16
Sigma-Aldrich Launches Ascentis Express HPLC Columns 17
7. MAJOR PLAYERS 17
Albemarle Corporation (USA) 17
BASF AG (Germany) 17
Cambrex Corp. (USA) 17
Chiral Quest Inc (US) 18
Dalco ChromTech AB (Sweden) 18
Daicel Chemical Industries Ltd. (Japan) 18
DSM Pharmaceutical Products (Netherlands) 18
Dowpharma(SM) (USA) 19
Johnson Matthey PLC (UK) 19
Regis Technologies Inc (USA) 19
Shasun Chemicals and Drugs Limited (India) 19
Solvias (Switzerland) 20
Sigma Aldrich Corp (USA) 20
Suven Life Sciences Ltd (USA) 20
8. GLOBAL MARKET ANALYTICS 21
9. THE UNITED STATES 27
Overview 27
10. JAPAN 28
11. EUROPE 30
12. REST OF WORLD 32
India 32
Chiral Drugs in the Indian Market 32
China-A Hub for Pharmaceutical Manufacturing 32
EXHIBITS
Table 1: Percentage Breakdown of Chiral Technology
Manufacturer Revenues by Techniques in the World - 2010
Table 2: Sales of Leading Single-Enantiomer Drugs Brand in the
World - 2006 (In US$ Billion)
Table 3: Global Chiral Technology Enabling Products Market by
Region for the Period 2007-2015 (Sales in US$ Million)
Table 4: Percentage Breakdown of Global Chiral Technology
Enabling Products Market by Region for the Years 2008 & 2012
Table 5: Global Chiral Intermediates Market by Region for the
Period 2007-2015 (Sales in US$ Million)
Table 6: Percentage Breakdown of Global Chiral Intermediates
Market by Region for the Years 2008 & 2012
Table 7: Global Chiral Analytical Products Market by Region
for the Period 2007- 2015 (Sales in US$ Million)
Table 8: Percentage Breakdown of Global Chiral Analytical
Products Market by Region for the Years 2008 & 2012
Table 9: Global Other Chiral Technology Enabling Products
Market by Region for the Period 2007-2015 (Sales in US$
Million)
Table 10: Percentage Breakdown of Global Other Chiral
Technology Enabling Products Market by Region for the Years
2008 & 2012
Table 11: Global Chiral Technology in Pharmaceuticals Market
by Region for the Period 2007-2015 (Sales in US$ Million)
Table 12: Percentage Breakdown of Global Chiral Technology in
Pharmaceuticals Market by Region for the Years 2008 & 2012
Table 13: Global Chiral Technology in Agrochemicals Market by
Region for the Period 2007-2015 (Sales in US$ Million)
Table 14: Percentage Breakdown of Global Chiral Technology in
Agrochemicals Market by Region for the Years 2008 & 2012
Table 15: Chiral Technology Enabling Products Market by
Segment in the US: 2007-2015 (Sales in US$ Million)
Table 16: Percentage Breakdown of Chiral Technology Enabling
Products Market by Segment in the US for the Years 2008 & 2012
Table 17: Chiral Technology Market by End-Use Segment in the
US: 2007- 2015 (Sales in US$ Million)
Table 18: Percentage Breakdown of Chiral Technology Market by
End-Use Segment in the US for the Years 2008 & 2012
Table 19: Chiral Technology Enabling Products Market by
Segment in Japan: 2007-2015 (Sales in US$ Million)
Table 20: Percentage Breakdown of Chiral Technology Enabling
Products Market by Segment in Japan for the Years 2008 & 2012
Table 21: Chiral Technology Market by End-Use Segment in
Japan: 2007-2015 (Sales in US$ Million)
Table 22: Percentage Breakdown of Chiral Technology Market by
End-Use Segment in Japan for the Years 2008 & 2012
Table 23: Chiral Technology Enabling Products Market by
Segment in Europe: 2007-2015 (Sales in US$ Million)
Table 24: Percentage Breakdown of Chiral Technology Enabling
Products Market by Segment in Europe for the Years 2008 & 2012
Table 25: Chiral Technology Market by End-Use Segment in
Europe: 2007- 2015 (Sales in US$ Million)
Table 26: Percentage Breakdown of Chiral Technology Market by
End-Use Segment in Europe for the Years 2008 & 2012
Table 27: Chiral Technology Enabling Products Market by
Segment in Rest of World: 2007-2015 (Sales in US$ Million)
Table 28: Percentage Breakdown of Chiral Technology Enabling
Products Market by Segment in Rest of World for the Years 2008
& 2012
Table 29: Chiral Technology Market by End-Use Segment in Rest
of World: 2007-2015 (Sales in US$ Million)
Table 30: Percentage Breakdown of Chiral Technology Market by
End-Use Segment in Rest of World for the Years 2008 & 2012
COMPANIES PROFILED
To order this report:
Pharmaceutical Industry: Chiral Technology - International Technology & Market Trends
Nicolas Bombourg Reportlinker Email: nbo@reportlinker.com US: (805)652-2626 Intl: +1 805-652-2626
SOURCE Reportlinker
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |